protocatechualdehyde has been researched along with allopurinol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Beedham, C; Panoutsopoulos, GI | 1 |
| Haubner, R; Khallouki, F; Owen, RW; Ulrich, CM | 1 |
| Chen, C; Lü, JM; Yao, Q | 1 |
4 other study(ies) available for protocatechualdehyde and allopurinol
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Enzymatic oxidation of vanillin, isovanillin and protocatechuic aldehyde with freshly prepared Guinea pig liver slices.
Topics: Allopurinol; Animals; Benzaldehydes; Catechols; Enzyme Inhibitors; Female; Guinea Pigs; Liver; Molecular Structure; Oxidation-Reduction | 2005 |
Ethnobotanical survey, chemical composition, and antioxidant capacity of methanolic extract of the root bark of Annona cuneata Oliv.
Topics: Annona; Antioxidants; Benzaldehydes; Benzyl Alcohols; Catechols; Chromatography, High Pressure Liquid; Democratic Republic of the Congo; Ethnobotany; Gallic Acid; Gas Chromatography-Mass Spectrometry; Methanol; Phenols; Plant Extracts; Plant Roots; Vanillic Acid; Xanthine Oxidase | 2011 |
3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: a potential therapeutic agent for treatment of hyperuricemia and gout.
Topics: Administration, Oral; Allopurinol; Animals; Antioxidants; Benzaldehydes; Catechols; Cell-Free System; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Gout Suppressants; Hyperuricemia; Inhibitory Concentration 50; Mice; Mice, Inbred C57BL; Molybdenum; Reactive Oxygen Species; Structure-Activity Relationship; Uric Acid; Xanthine Oxidase | 2013 |